Catheter Precision, Inc. Common Stock
Key Metrics
- Previous Close
- $0.21
- 52-Week Range
- $0.19 – $3.20
- Market Cap
- $753.66K
- P/E (TTM)
- —
- EPS (TTM)
- -4.07
- Dividend Yield
- —
Advanced Metrics
- Price/Book
- 0.04
- PEG Ratio
- —
- Return on Equity
- -111.35%
- Return on Assets
- -24.15%
- Gross Margin
- 47.73%
- Operating Margin
- -388.13%
- Profit Margin
- 0.00%
- Current Ratio
- 0.19
- Debt/Equity
- 0.80
- Total Debt
- $13.65M
- Free Cash Flow
- $-4.38M
- Revenue Growth
- 380.70%
- Earnings Growth
- —
- Enterprise Value
- $14.40M
Market Snapshot
About
Catheter Precision, Inc. Common Stock (VTAK) is a medical technology company focused on the field of cardiac electrophysiology, often shortened to EP. The company designs, manufactures, and sells its technologies in the United States and Europe, and is based in Fort Mill, South Carolina. It was formerly known as Catheter Robotics Inc. The company is known for tools that support diagnosis and procedures related to heart rhythm conditions.
The company's lead product is the View into Ventricular Onset System. This is a non-invasive imaging system that provides 3D cardiac mapping. Its purpose is to help locate the sites of origin of idiopathic ventricular arrhythmias in patients who have structurally normal hearts, and this mapping is done before electrophysiology procedures. By identifying where abnormal heart rhythms begin ahead of a procedure, the system is intended to assist physicians in planning their work.
Catheter Precision also offers LockeT, a suture retention device. LockeT is designed to temporarily secure sutures and to aid clinicians in locating and removing sutures, supporting the practical steps involved in closing access sites used during procedures.
Together, these products reflect a focus on cardiac electrophysiology, which deals with the electrical activity of the heart and the treatment of arrhythmias. The View into Ventricular Onset System addresses the diagnostic and mapping side of care, while LockeT addresses a procedural need related to sutures. By developing and selling these devices across the United States and Europe, Catheter Precision, Inc. serves clinicians who treat heart rhythm disorders, and its activity centers on the design, manufacture, and sale of these specialized medical technologies.